Microparticles and autophagy: a new frontier in the understanding of atherosclerosis in rheumatoid arthritis

被引:0
|
作者
C. Barbati
M. Vomero
T. Colasanti
F. Ceccarelli
M. Marcosano
F. Miranda
L. Novelli
A. Pecani
Carlo Perricone
F. R. Spinelli
S. Truglia
F. Conti
G. Valesini
C. Alessandri
机构
[1] Sapienza University of Rome,Arthritis Center, Department of Internal Medicine and Medical Specialties
来源
Immunologic Research | 2018年 / 66卷
关键词
Microparticles; Autophagy; Atherosclerosis; Rheumatoid arthritis;
D O I
暂无
中图分类号
学科分类号
摘要
Microparticles (MPs) are small membrane vesicles released by many cell types under physiological and pathological conditions. In the last years, these particles were considered as inert cell debris, but recently many studies have demonstrated they could have a role in intercellular communication. Increased levels of MPs have been reported in various pathological conditions including infections, malignancies, and autoimmune diseases, such as rheumatoid arthritis (RA). RA is an autoimmune systemic inflammatory disease characterized by chronic synovial inflammation, resulting in cartilage and bone damage with accelerated atherosclerosis increasing mortality. According to the literature data, also MPs could have a role in endothelial dysfunction, contributing to atherosclerosis in RA patients. Moreover many researchers have shown that a dysregulated autophagy seems to be involved in endothelial dysfunction. Autophagy is a reparative process by which cytoplasmic components are sequestered in double-membrane vesicles and degraded on fusion with lysosomal compartments. It has been shown in many works that basal autophagy is essential to proper vascular function. Taking into account these considerations, we hypothesized that in RA patients MPs could contribute to atherosclerosis process by dysregulation of endothelial autophagy process.
引用
收藏
页码:655 / 662
页数:7
相关论文
共 50 条
  • [31] Predictors of atherosclerosis in rheumatoid arthritis.
    Wallberg-Jonsson, S
    Ohman, ML
    Rantapaa-Dahlqvist, S
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S54 - S54
  • [32] Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents
    Federico Carbone
    Aldo Bonaventura
    Luca Liberale
    Sabrina Paolino
    Francesco Torre
    Franco Dallegri
    Fabrizio Montecucco
    Maurizio Cutolo
    Clinical Reviews in Allergy & Immunology, 2020, 58 : 1 - 14
  • [33] Subclinical atherosclerosis in rheumatoid arthritis patients
    Rednic, S
    Rednic, NR
    Damian, L
    Nicoara, I
    Fodor, D
    Bolosiu, HD
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 197 - 197
  • [34] Accelerated atherosclerosis in the context of rheumatoid arthritis
    Backlund, A.
    Johansson, M.
    Ria, M.
    Ketelhulth, D. F.
    Tsikrika, P.
    Chernogubova, E.
    Jin, H.
    Backlund, J.
    Eriksson, P.
    Maegdefessel, L.
    Holmdahl, R.
    Hansson, G. K.
    Hamsten, A.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 440 - 441
  • [35] Atherosclerosis in Rheumatoid Arthritis: Predictive Factors
    Parvu, Mirela
    Fit, Lucia Carmen
    Opris, Daniela
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S32 - S33
  • [36] Evaluation of Leptin with Atherosclerosis in Rheumatoid Arthritis
    Agilli, Mehmet
    Aydin, Fevzi Nuri
    Kurt, Yasemin Gulcan
    Cayci, Tuncer
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (04) : 727 - 727
  • [37] Atherosclerosis and Cardiovascular Disease in Rheumatoid Arthritis
    Frostegard, Johan
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (12) : 2233 - 2234
  • [38] Understanding hypercitrullination in rheumatoid arthritis
    Katrina Ray
    Nature Reviews Rheumatology, 2014, 10 (1) : 3 - 3
  • [39] Understanding IFNλ in rheumatoid arthritis
    de Groen, Rik A.
    Liu, Bi-Sheng
    Boonstra, Andre
    ARTHRITIS RESEARCH & THERAPY, 2014, 16 (01)
  • [40] Rheumatoid arthritis - A molecular understanding
    Smith, JB
    Haynes, MK
    ANNALS OF INTERNAL MEDICINE, 2002, 136 (12) : 908 - 922